Workflow
惠氏启赋
icon
Search documents
雀巢“渡劫”?惠氏中国员工批量“毕业”震荡未平,婴配粉又陷全球召回危机
3 6 Ke· 2026-01-08 04:17
雀巢最近摊上事儿了。 因发现产品原料存在质量问题,近期雀巢多款婴配粉启动了全球范围的预防性召回,食品安全危机引发大批消费者恐慌,波及集团旗下品牌包括能恩、惠 氏、BEBA等。 此外,内参君获悉,因雀巢与惠氏中国婴儿营养业务合并,雀巢在年末岁初启动了对部分岗位的人员优化。受裁撤影响,留任的一线员工因相关管理团 队、政策未到位,也深陷业务停滞、未来方向不明的迷茫。 时间回溯至2025年12月初,雀巢在大中华区宣布,计划将其惠氏营养品业务与雀巢婴儿营养品业务合并,成立"雀巢营养品"业务单元,由雀巢婴儿营养原 负责人谢国耀出任新业务总裁。 2026年1月1日,"雀巢营养品"新业务单元正式揭牌,惠氏中国与雀巢婴儿营养业务的合并落地。据公开报道,合并后的业务团队融合了原雀巢和惠氏的双 方人员,且将由两个独立的市场部团队分别负责原来雀巢婴儿营养品旗下的能恩和嘉宝品牌,以及原来惠氏营养品旗下的启赋和S-26品牌。 尽管雀巢中国方强调此次业务整合"不影响现有业务开展",但在一线市场,业务合并后的阵痛已逐步显现。 内参君从多方获悉,自合并消息公布后,惠氏对在华人员进行了调整优化,一线导购批量"毕业"或"提前退休",波及省份包括但 ...
雀巢在欧洲多国召回婴儿奶粉 雀巢中国回应:少数产品或受影响 已回收特定批次奶粉
Xin Lang Cai Jing· 2026-01-07 05:13
1月7日午间消息,雀巢公司近日宣布,因供应商提供的某一种原料存在"质量问题",在德国、奥地利、 丹麦、意大利、瑞典等欧洲国家预防性召回一批婴儿配方奶粉。 雀巢公司在其网站发布声明说,已对可能受影响的产品进行了花生四烯酸(ARA)油脂及相关油脂混 合物检测。截至目前,尚未接到因食用该配方奶粉导致不适或患病的报告。 该公司同时公布了召回产品的图片和批次编号。这款奶粉在不同国家的商品名有所不同。 | RATIST LE UNIVERSITY FOR | MILIANAGER | rzaslanda | | --- | --- | --- | | 惠氏Wyeth自赋未来3段 | 52470017C3 | 04/09/2027 | | 惠氏Wyeth雇赋有机2段 | 51620017C1 | 11/06/2027 | | 惠氏Wyeth息赋有机3段 | 51620017C2 | 11/06/2027 | | 雀巢能恩全护A2 GHMO 1段 | 51250017C1 | 05/05/2027 | | 蛋巢能恩全护A2 6HMO2段 | 51260017C1 | 06/05/2027 | | 蛋巢能恩全护A2 6HMO2 ...
达能周志刚或升职:爱他美们与医学营养品一起管
Group 1 - Danone is restructuring its leadership in China, appointing Zhou Zhigang to lead its specialized nutrition business starting January 1, 2026, as part of its "Revitalizing Danone" strategy [1][2] - The restructuring aims to create a more streamlined leadership structure to accelerate transformation and enhance focus and agility in operations [1] - Danone's CEO has identified medical nutrition as a significant long-term growth opportunity, with adult medical nutrition in China experiencing double-digit growth annually for over a decade [2] Group 2 - Nestlé is also merging its Wyeth Nutrition and Nestlé infant nutrition businesses into a single unit, effective January 1, 2026, with Joel Seah as the head [3] - The infant formula market is under pressure, with Nielsen IQ reporting a growth rate of only 0.6% in the second quarter of 2025, and a decline in marriage registrations in China by over 20% in 2024 [4] - Despite foreign brands maintaining a brand advantage, domestic brands like Feihe and Yili have surpassed foreign companies in market share as of 2022 [4][5]
达能周志刚或升职:爱他美们与医学营养品一起管丨消费参考
Group 1 - Foreign companies are streamlining their operations in China, with Danone appointing Zhou Zhigang as the head of its specialized nutrition business starting January 1, 2026 [1][2] - Danone's organizational restructuring aims to accelerate transformation and enhance focus and agility, aligning with its "Revitalizing Danone" strategy [2][3] - Danone's CEO highlighted medical nutrition as a significant long-term growth opportunity, with adult medical nutrition in China experiencing double-digit growth annually for over a decade [3] Group 2 - Nestlé is also merging its Wyeth Nutrition and Nestlé Infant Nutrition businesses into a single unit, effective January 1, 2026, with Joel Seah as the head [4] - The baby formula market is under pressure, with Nielsen IQ reporting a growth rate of only 0.6% in Q2 2025, and a decline in marriage registrations by over 20% in 2024 [5] - Despite foreign brands maintaining a competitive edge, domestic brands like Feihe and Yili have surpassed foreign companies in market share [5][6]
雀巢婴儿营养与惠氏营养品在华合并,意在重拾增长势头
Xin Jing Bao· 2025-12-03 09:43
近日有消息传出,雀巢大中华区将于2026年1月1日起成立雀巢营养品业务单元,其中一项重要举措是将 雀巢和惠氏两大婴儿营养业务进行合并,由雀巢婴儿营养业务负责人谢国耀担任新业务部门负责人。12 月2日,雀巢方面向新京报记者证实了上述消息,并称婴儿营养始终是其核心业务,此次整合将帮助其 重拾增长势头。 资料显示,自2012年被雀巢收购以来,惠氏营养品一直保持独立运作,一度借助高端品类稳坐中国婴幼 儿奶粉市场第一宝座。2019年-2021年,受人口出生率下降、国产奶粉品牌崛起及市场竞争加剧等因素 影响,惠氏主要系列产品在中国市场销量出现下滑。经过一系列策略调整,雀巢大中华区婴幼儿营养业 务2022年、2023年实现复苏,但2024年再次下降。第三方数据显示,截至2024年底,雀巢、惠氏在中国 婴幼儿奶粉市场整体份额位列第四,但单独品牌份额已分别掉落至第七、第八位。 此次合并之所以受到外界关注,在于惠氏营养品被雀巢收购的过往13年里,一直独立运作于雀巢婴儿营 养业务之外。 分析认为,雀巢与惠氏婴儿营养业务在中国市场合并,主要目的是提高组织效率,实现"降本增效",提 高整体有效竞争力。 收购13年后首次业务合并 雀巢方 ...
新帅在华“动刀”:雀巢、惠氏营养品合并
雀巢正在经历一场自上而下的大改革。 2025年12月1日,雀巢中国向21世纪经济报道记者确认,惠氏营养品业务和雀巢婴儿营养品业务两大业 务单元将于2026年1月1日起正式合并,成立雀巢营养品业务。谢国耀(Joel Seah)将成为该业务的负责 人。 对此,雀巢大中华区董事长兼首席执行官马凯思向员工表示:"这不是倒退,而是为了一个更加美好的 开篇。" "婴儿营养始终是我们的核心业务,我们将继续加大对品牌和渠道的投资。在业务调整过程中,公司严 格依法合规执行。调整不影响现有业务开展,惠氏营养品(中国)有限公司和惠氏(上海)贸易有限公 司将继续运行,惠氏启赋、S-26等品牌将继续服务中国消费者。"雀巢方面如此向21世纪经济报道记者 回应称。 竞争变难 "这一整合将帮助我们重拾增长势头,巩固在中国婴儿营养市场的领导地位。"对于此次整合,雀巢中国 如此解释。 背后是,雀巢婴儿营养板块的核心市场婴配粉行业正走向存量。 毕竟,在婴配粉市场,国产品牌已经占据主导位置。欧睿数据显示,飞鹤、伊利早在2022年就已超越外 资跻身前二。 由此,对雀巢中国来说,将惠氏营养品业务与雀巢婴儿营养品业务两大业务单元合并,有助于减少内 耗,形 ...
雀巢,联合作战
Sou Hu Cai Jing· 2025-12-02 17:07
12月2日,雀巢方面向《消费钛度》证实称,雀巢将迎来新的组织架构调整:在大中华区市场,惠氏营 养品业务和雀巢婴儿营养品业务计划合并,并于2026年1月1日正式成立雀巢营养品业务,深耕母婴市场 多年的老将谢国耀(Joel Seah)将成为该业务的负责人。 这一整合动作,不仅标志着两大外资营养品巨头在华业务的深度融合,更被视作外资品牌应对中国市场 变局的关键落子。这场"联合作战"能否改写行业格局,成为市场关注的核心焦点。在业内人士看来,雀 巢与惠氏的合并具有显著的协同效应,新业务单元有望通过品牌、产品、渠道的三重整合打开增长空 间。 从收购到合并 作为雀巢旗下定位于高端奶粉的品牌,惠氏于2012年被雀巢以118.5亿美元从辉瑞旗下收购,收购完成 后,惠氏保持独立运营,雀巢对其进行"嵌入式"管理,让惠氏保留品牌、渠道、团队独立性,雀巢与其 共享渠道、供应链资源。 目前,惠氏旗下主要有惠氏启赋、S-26等品牌。而雀巢自身婴儿营养品旗下品牌则包括雀巢能恩、嘉宝 等,主要聚焦于婴幼儿营养和特殊医学用途配方奶粉。 此次合并的核心掌舵者谢国耀,其履历背景为这场整合增添了更多确定性。据悉,谢国耀拥有超过20年 快消品行业经验, ...
雀巢、惠氏营养品将被合并
21世纪经济报道· 2025-12-02 09:45
记者丨 贺泓源 编辑丨高梦阳 雀巢正在经历一场自上而下的大改革。 2025年12月1日,雀巢中国向21世纪经济报道记者确认, 惠氏营养品业务和雀巢婴儿营养品业 务两大业务单元将于2026年1月1日起正式合并,成立雀巢营养品业务 。谢国耀(Joel Seah) 将成为该业务的负责人。 对此,雀巢大中华区董事长兼首席执行官马凯思向员工表示:"这不是倒退,而是为了一个更 加美好的开篇。" "婴儿营养始终是我们的核心业务,我们将继续加大对品牌和渠道的投资。在业务调整过程 中,公司严格依法合规执行。调整不影响现有业务开展,惠氏营养品(中国)有限公司和惠氏 (上海)贸易有限公司将继续运行,惠氏启赋、S-26等品牌将继续服务中国消费者。"雀巢方 面如此向21世纪经济报道记者回应称。 | | 集团 | 美洲 | 亚洲、大洋洲 | 欧洲 | 発菓 | 奈斯 | 雀巢水和 | 真他 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 总计 | 大区 | 和非洲大区 | 大区 | 健康科学 | 派索 | 高端饮料业务 | 业务 | | 2025年前九个月销售额 ...
外资奶粉在中国不香了,昔日一哥惠氏将被雀巢合并
Guan Cha Zhe Wang· 2025-12-02 01:57
Core Insights - Nestlé Group is integrating its Wyeth Nutrition and Nestlé Infant Nutrition units to form a new "Nestlé Nutrition" team in China starting January 1, 2026, with Joel Seah as the head of the merged business [1] - The integration aims to enhance growth momentum and strengthen Nestlé's leadership position in the Chinese infant nutrition market [1] Financial Performance - Nestlé's global sales for the first nine months of 2025 were 65.9 billion Swiss francs, a year-on-year decline of approximately 1.9% [1] - The Greater China region experienced an organic growth rate of -6.1%, with an internal growth rate of -2.9% and a pricing contribution rate of -3.2% [1] Strategic Changes - New CEO Philipp Navratil has prioritized improving internal growth rates and is implementing a comprehensive strategy to streamline operations, eliminate inefficiencies, and maximize the value of existing assets [2] - The focus is shifting from expensive non-organic growth to leveraging synergies and enhancing profitability across existing business units [2] Market Challenges - The Chinese infant formula market is facing challenges such as declining birth rates and increased competition, leading to a further decline in Wyeth's market share [2] - The market dynamics have shifted significantly, with domestic brands gaining ground and foreign brands like Wyeth experiencing a drop in market presence [2] Competitive Landscape - In 2019, the market shares of Feihe and Nestlé were nearly equal at 13.3% and 13.5%, respectively; however, by 2022, Feihe's market share increased to 17.5%, while Nestlé's fell to 10.7% [3] - The implementation of new national standards for infant formula presents an opportunity for Wyeth, as it was the first foreign brand to have all its products registered under the new standards [3] Operational Continuity - The restructuring will not affect the ongoing operations of Wyeth Nutrition (China) Co., Ltd. and Wyeth (Shanghai) Trading Co., Ltd., and brands like Wyeth Illuma and S-26 will continue to serve Chinese consumers [4]
新帅在华动刀:雀巢、惠氏营养品合并
Core Viewpoint - Nestlé is undergoing a significant restructuring, merging its Wyeth Nutrition and Nestlé Infant Nutrition units into a single Nestlé Nutrition business starting January 1, 2026, to enhance growth and consolidate its leadership in the Chinese infant nutrition market [1][9]. Group 1: Business Restructuring - The merger aims to reduce internal competition and leverage the strong brand influence of Wyeth and the operational advantages of Nestlé's infant nutrition team [10][9]. - Joel Seah will lead the newly formed Nestlé Nutrition business [1]. - The restructuring is part of a broader strategy to prioritize high-potential opportunities and foster a performance-oriented culture within the company [13]. Group 2: Market Dynamics - The infant formula market in China is experiencing stagnation, with a growth rate of only 0.6% in Q2 2025, as the new birth rate declines and marriage registrations drop by over 20% in 2024 [4]. - The ultra-premium segment is becoming mainstream, with a 13.3% year-on-year growth in the ultra-premium+ market, while other segments are declining [5]. - Domestic brands like Feihe and Yili have surpassed foreign brands in market share, indicating a shift in competitive dynamics [8]. Group 3: Financial Performance - Nestlé's organic growth rate in the Greater China region was -10.4% in Q3, continuing a downward trend from Q2, highlighting the operational pressures faced by the company [10]. - The overall sales figures for the first nine months of 2025 show a slight decline compared to the same period in 2024, with total sales of 65,869 million Swiss francs [3]. Group 4: Leadership Changes - Recent leadership changes include the appointment of a new CEO, who emphasizes a cautious approach to resource allocation and a focus on growth [12][13]. - The restructuring is being executed under the guidance of the new management team, which includes key personnel with experience in the Southeast Asian market [16][15].